SRSaltanat Rakhimzhanova

Saltanat Rakhimzhanova

*This is an algorithmically generated author record based on publicly available information.

Saltanat Rakhimzhanova has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Whole-exome sequencing of kidney transplant recipients and donors: insights into end-stage renal disease and post-transplant genetic risk

    by Mirgul Bayanova, Aidos Bolatov, Dias Malik, Malika Sapargaliyeva, Aizhan Abdikadirova, Aida Zhenissova, Lyazzat Nazarova, Mels Assykbayev, Saitkarim Abdugafarov, Saltanat Rakhimzhanova, et al.

    Kidney transplantation is the preferred treatment for end-stage renal disease (ESRD), yet challenges persist in long-term graft survival and post-transplant complications. Genomic profiling, especially whole-exome sequencing (WES), offers new opportunities to personalize donor-recipient matching and predict transplant outcomes. This study aimed to explore the genetic landscape of both transplant recipients and donors using WES. This prospective cohort study included 64 kidney transplant recipients (51 adults, 13 pediatric) and 61 donors in Kazakhstan. WES was performed to identify monogenic causes of ESRD, evaluate rejection-associated immune polymorphisms (31 SNPs), and screen for post-transplant risk using a 355-gene Transplant Morbidity Panel. Variants were classified following ACMG/AMP guidelines, and allele frequencies were compared to global reference datasets. Among recipients, pathogenic/likely pathogenic variants were found in 15.4% of pediatric and 9.1% of adult cases, with additional variants of uncertain significance detected in 23.1% and 23.6%, respectively. WES identified monogenic nephropathies including Alport syndrome, cystinuria, and polycystic kidney disease. In donors, 13.1% carried variants associated with latent renal or systemic conditions despite no clinical manifestation at donation. The APOE p.Cys130Arg variant, linked to lipid dysregulation, was observed more frequently in recipients (allele frequency 0.17) than donors (0.09), though not statistically significant. Among the 31 SNPs evaluated, significant associations with acute rejection were observed for IL1B rs1143634 and TP53 rs1625895 under dominant models. IL1B carriers showed increased rejection risk (OR = 4.62, p = 0.039), whereas TP53 carriers appeared protected (OR = 0.058, p = 0.027). Given the limited number of rejection cases, these findings should be considered exploratory and require validation in larger cohorts. Additionally, 44.3% of recipients carried at least one pathogenic or likely pathogenic variant in the Transplant Morbidity Panel, particularly in genes related to malignancy, cardiomyopathy, and monogenic diabetes. This study provides one of the first applications of WES in a Central Asian kidney transplant population. Findings highlight the prevalence of monogenic and comorbid risk variants in both recipients and donors and support the use of genomic screening for improving pre- and post-transplant care. The identification of immune-related SNPs and extra-renal findings further underscores the utility of WES for personalized transplant management. Integration of genomics into transplant workflows may help address the ongoing gap between clinical need and transplant outcomes, particularly in low-resource settings.


  • Open Access

    Beyond Survival: A 12-Year Chronicle of Pediatric Kidney Transplantation in Kazakhstan

    by Deniza Suleimenova, Saltanat Rakhimzhanova, Aidos Bolatov, Ardak Ainakulov, Sholpan Altynova, Yuriy Pya

    Pediatric kidney transplantation (KTx) is a life-saving procedure for children with end-stage renal disease (ESRD), yet outcomes and risk factors remain underreported in Central Asia. We aimed to provide valuable insights into the long-term impact of KTx on pediatric patients. Materials and methods: This article presents a retrospective review of 12-year experience of pediatric KTx at the «University Medical Center» Corporate Fund (Astana, Kazakhstan). The analysis included the records of 146 patients under the age of 18. The characteristics of the patients included causes of chronic kidney disease (CKD), clinical features and transplantation outcomes: overall survival (OS), graft survival (GS), graft loss (GL), transplant rejection (TR) and complications. Results: Of 146 recipients (mean age 139 months, 56.8% male), the leading cause of ESRD was congenital anomalies of the kidney and urinary tract (CAKUT, 50.7%). Living donor KTx (LDKT) accounted for 73%, while Deceased donor KTx (DDKT). TR occurred in 18.5% of cases and was significantly associated with GL (OR = 7.19, 95% CI: 2.55-20.25, p < 0.001). GL occurred in 13.0% of patients, and mortality was 6.2%. Complications were reported in 43.8% of patients and were significantly associated with mortality (p = 0.034). No association between donor type (LDKT vs. DDKT) and rejection was found. Gender, diagnosis, BMI, age at transplantation, donor type were not significant predictors of GL or patient death. Conclusion: Pediatric KTx in Kazakhstan demonstrates promising outcomes, with relatively low mortality (6.2%) and GL (13.0%) rates. TR (occurred in 18.5% patients) significantly predicts GL, while post-Tx complications (occurred in43.8% of patients) are associated with decreased patient survival. These findings support the need for improved early monitoring and long-term management strategies to optimize outcomes. Keywords: kidney transplantation, child, graft loss, rejection, complication, survival analysis


  • Open Access

    Kidney transplantation in children in the Republic of Kazakhstan

    by Sholpan Altynova, Aliya Sailybayeva, Saule Shaisultanova, Gulnur Daniyarova, Aigerim Abdiorazova, Gani Kuttymuratov, Ardak Ainakulov, Samat Issakov, Saltanat Rakhimzhanova, Yuriy Pya

    Зерттеудің мақсаты: Ұлттық ғылыми ана мен бала орталығында (Астана қаласы) кешенді бағдарлама құрылған сәттен бастап жүзеге асырылатын созылмалы бүйрек жеткіліксіздігінің соңғы сатысы бар балалардағы бүйрек трансплантациясының клиникалық тәжірибесін талдау. Зерттеудің нақты мақсаттары: науқастардың өмір сапасын бағалау, сәтсіз бүйрек трансплантациясының себептерін талдау және балаларға бүйрек трансплантациясының ерекшеліктері туралы мәселені шешу болып табылады.Әдістері. Бұл зерттеу ретроспективті когорттық зерттеу болып табылады. Деректер осы популяциядағы бүйректрансплантациясының тиімділігі мен нәтижелерін бағалау үшін медициналық жазбалардан ретроспективті түрде қаралды.Нәтижелер. Гемодиализ немесе перитонеальді диализ алған балалармен салыстырғанда бүйрек трансплантациясы бар созылмалы бүйрек жеткіліксіздігінің соңғы сатысы бар балаларда өлім-жітім айтарлықтай төмен және өмір сапасыайтарлықтай жоғары. Трансплантацияның түсуі және өлім көрсеткіші сәйкесінше 17 (13,4%) және 7 (5,9%) жағдайда болды.Қорытынды. Деректер трансплантацияның, әсіресе тірі донорлардың өмір сүруінде айтарлықтай табысқа қол жеткізгенін көрсетеді: жылдық, бес жылдық және он жылдық өмір сүру деңгейі сәйкесінше 92%, 79% және 76% құрайды.